Dawei Ye

5.8k citations

72 papers · 3.8k indexed · 4 hit papers · h-index 34

Impact in

Infectious Diseases top 2%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
Physiology top 2%
- Pain Mechanisms and Treatments

Papers in ⓘ

Physiology 26
- Pain Mechanisms and Treatments 22
Pharmacology 7
- Pharmacological Effects of Natural Compounds 7

Co-authors: Ya‐Qun Zhou (28 shared papers)Qingquan Liu (6 shared papers)Yiru Wang (4 shared papers)Lisheng Wang (1 shared paper)Yuke Tian (23 shared papers)Shuping Chen (15 shared papers)Jia Sun (14 shared papers)Dai-Qiang Liu (14 shared papers)
Journals: Biomedicine & Pharmacotherapy (5 papers)Oncotarget (3 papers)Pharmacological Research (3 papers)International Journal of Antimicrobial Agents (2 papers)Frontiers in Public Health (2 papers)
Partner nations: China United States United Kingdom

In The Last Decade

Dawei Ye

72 papers receiving 3.8k citations

Hit Papers

align trajectories log scale

Histone lactylation-driven B7-H3 expression promotes tumor immune evasion 2025 · 26 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2025 Theranostics
2024 Cell Metabolism
2020 International Journal of Antimicrobial Agents
2016 Journal of Neuroinflammation

Peers

Countries citing papers authored by Dawei Ye

Since Specialization

Citations

This map shows the geographic impact of Dawei Ye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dawei Ye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dawei Ye more than expected).

Fields of papers citing papers by Dawei Ye

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dawei Ye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dawei Ye. The network helps show where Dawei Ye may publish in the future.

Co-authors

The 25 scholars most cited alongside Dawei Ye, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Dawei Ye Line = papers co-authored together Dawei Ye links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 72 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Review of the 2019 novel coronavirus (SARS-CoV-2) based on current evidence International Journal of Antimicrobial Agents ·Lisheng Wang, Yiru Wang, Dawei Ye, Qingquan Liu Hit paper breakdown →	2020	801
2	Interleukin-6: an emerging regulator of pathological pain Journal of Neuroinflammation ·Ya‐Qun Zhou, Zheng Liu, Zhiheng Liu, Shuping Chen, Man Li, Allahverdi Shahveranov, Dawei Ye, Yuke Tian Hit paper breakdown →	2016	317
3	Carbon Monoxide and Its Controlled Release: Therapeutic Application, Detection, and Development of Carbon Monoxide Releasing Molecules (CORMs) Journal of Medicinal Chemistry ·Ken Ling, Fang Men, Wei-Ci Wang, Ya‐Qun Zhou, Haowen Zhang, Dawei Ye	2017	257
4	Targeting JAK-STAT Signaling to Control Cytokine Release Syndrome in COVID-19 Trends in Pharmacological Sciences ·Wei Luo, Yixin Li, Lijun Jiang, Qian Chen, Tao Wang, Dawei Ye	2020	219
5	Diagnostic performance of initial blood urea nitrogen combined with D-dimer levels for predicting in-hospital mortality in COVID-19 patients International Journal of Antimicrobial Agents ·Anying Cheng, Hu Liu, Yiru Wang, Luyan Huang, Lingxi Zhao, Congcong Zhang, Xiyue Liu, Ranran Xu, Feng Liu, Jin‐Ping Li, Dawei Ye, Tao Wang, Yongman Lv, Qingquan Liu	2020	97
6	Targeting TNF-α for COVID-19: Recent Advanced and Controversies Frontiers in Public Health ·Yi Guo, Ke Hu, Yuxuan Li, Chanjun Lu, Ken Ling, Chuanqi Cai, Weici Wang, Dawei Ye	2022	94
7	Role of curcumin in the management of pathological pain Phytomedicine ·Jia Sun, Fei Chen, Cody Braun, Ya‐Qun Zhou, Heike L. Rittner, Yuke Tian, Xiuyu Cai, Dawei Ye	2018	91
8	Nrf2 activation ameliorates mechanical allodynia in paclitaxel-induced neuropathic pain Acta Pharmacologica Sinica ·Ya‐Qun Zhou, Dai-Qiang Liu, Shuping Chen, Nan Chen, Jia Sun, Xiaomei Wang, Fei Cao, Yuke Tian, Dawei Ye	2020	83
9	PI3K/Akt Pathway: A Potential Therapeutic Target for Chronic Pain Current Pharmaceutical Design ·Shuping Chen, Ya‐Qun Zhou, Dai-Qiang Liu, Wen Zhang, Anne Manyande, Xuehai Guan, Yuke Tian, Dawei Ye, Deeq Mohamed Omar	2017	81
10	Simultaneous inhibition of the ubiquitin-proteasome system and autophagy enhances apoptosis induced by ER stress aggravators in human pancreatic cancer cells Autophagy ·Xu Li, Feng Zhu, Jianxin Jiang, Chengyi Sun, Qing Zhong, Ming Shen, Xin Wang, Rui Tian, Chengjian Shi, Meng Xu, Feng Peng, Xingjun Guo, Jun Hu, Dawei Ye, Min Wang, Renyi Qin	2016	77
11	Reactive oxygen species scavengers ameliorate mechanical allodynia in a rat model of cancer-induced bone pain Redox Biology ·Ya‐Qun Zhou, Dai-Qiang Liu, Shuping Chen, Jia Sun, Xuerong Zhou, Heike L. Rittner, Wei Mei, Yuke Tian, Huixian Zhang, Fei Chen, Dawei Ye	2017	76
12	Berberine protects against ischemia-reperfusion injury: A review of evidence from animal models and clinical studies Pharmacological Research ·Dai-Qiang Liu, Shuping Chen, Jia Sun, Xiaomei Wang, Nan Chen, Ya‐Qun Zhou, Yuke Tian, Dawei Ye	2019	73
13	Development and Validation of a Nomogram for Assessing Survival in Patients With COVID-19 Pneumonia Clinical Infectious Diseases ·Yimin Dong, Jia Sun, Yixin Li, Qian Chen, Qingquan Liu, Zhou Sun, Ran Pang, Fei Chen, Bingyang Xu, Anne Manyande, Taane G. Clark, Jin‐Ping Li, İlkay Erdoğan Orhan, Tian Yuke, Tao Wang, Wei Wu, Dawei Ye	2020	73
14	What was the Epidemiology and Global Burden of Disease of Hip Fractures From 1990 to 2019? Results From and Additional Analysis of the Global Burden of Disease Study 2019 Clinical Orthopaedics and Related Research ·Yimin Dong, Yayun Zhang, Kehan Song, Honglei Kang, Dawei Ye, Feng Li	2022	68
15	STING/NF-κB/IL-6-Mediated Inflammation in Microglia Contributes to Spared Nerve Injury (SNI)-Induced Pain Initiation Journal of Neuroimmune Pharmacology ·Jia Sun, Ya‐Qun Zhou, Bingyang Xu, Jiayan Li, Long-Qing Zhang, Danyang Li, Shuang Zhang, Jiayi Wu, Shao‐Jie Gao, Dawei Ye, Wei Mei	2021	61
16	Minocycline as a promising therapeutic strategy for chronic pain Pharmacological Research ·Ya‐Qun Zhou, Dai-Qiang Liu, Shuping Chen, Jia Sun, Xiaomei Wang, Yuke Tian, Wei Wu, Dawei Ye	2018	61
17	Pharmacological inhibition of the NLRP3 inﬂammasome as a potential target for cancer-induced bone pain Pharmacological Research ·Shuping Chen, Ya‐Qun Zhou, Xiaomei Wang, Jia Sun, Fei Cao, Haitham Salem, Dawei Ye, Yuke Tian	2019	59
18	Global, Regional, and National Burden of CKD due to Glomerulonephritis from 1990 to 2019 Clinical Journal of the American Society of Nephrology ·Junjie Hu, Runjiang Ke, Wilhem Teixeira, Yimin Dong, Rong Ding, Jin-Cui Yang, Xing Ai, Dawei Ye, Jiwen Shang	2023	58
19	The therapeutic potential of Nrf2 inducers in chronic pain: Evidence from preclinical studies Pharmacology & Therapeutics ·Ya‐Qun Zhou, Wei Mei, Xuebi Tian, Yuke Tian, Dai-Qiang Liu, Dawei Ye	2021	53
20	Effect of PM2.5 air pollution on the global burden of lower respiratory infections, 1990–2019: A systematic analysis from the Global Burden of Disease Study 2019 Journal of Hazardous Materials ·Junjie Hu, Runxuan Zhou, Rong Ding, Dawei Ye, Yanbing Su	2023	50

About Dawei Ye

Dawei Ye is a scholar working on Physiology, Pharmacology, Biological Psychiatry, Neurology and Toxicology, having authored 72 papers that have together received 3.8k indexed citations. Recurring topics across this work include Pain Mechanisms and Treatments (22 papers), COVID-19 Clinical Research Studies (8 papers), Pharmacological Effects of Natural Compounds (7 papers), Cancer Treatment and Pharmacology (6 papers), Long-Term Effects of COVID-19 (6 papers), Neuropeptides and Animal Physiology (4 papers), Neuroinflammation and Neurodegeneration Mechanisms (4 papers) and Bone health and osteoporosis research (3 papers). The work is most often cited by research in Infectious Diseases (748 citations), Physiology (920 citations), Pharmacology (293 citations), Neurology (387 citations) and Modeling and Simulation (99 citations). Dawei Ye has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Ya‐Qun Zhou, Qingquan Liu, Yiru Wang, Lisheng Wang, Yuke Tian, Shuping Chen, Jia Sun, Dai-Qiang Liu, Ken Ling and Tao Wang. Their work appears in journals such as Biomedicine & Pharmacotherapy, Oncotarget, Pharmacological Research, International Journal of Antimicrobial Agents and Frontiers in Public Health.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact